Florian Moritz Heussen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Florian Moritz Heussen has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Damian Jaggi
Department of Ophthalmology, Inselspital, University Hospital Bern, Bern, Switzerland
5 shared publications - Martin Sebastian Zinkernagel
Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
4 shared publications - Gábor Márk Somfai
Department of Ophthalmology, Stadtspital Zürich Triemli, Zurich, Switzerland
3 shared publications - Klemens Paul Kaiser
Department of Ophthalmology, Goethe-University, Frankfurt, Germany
3 shared publications Matthias Dieter Becker
Department of Ophthalmology, Stadtspital Zürich, Zurich, Switzerland
3 shared publicationsFerhat Turgut
2 shared publications
Latest Publications
- 1 November 2026
- Published by Wolters Kluwer Health in Retina
- Vol. 46 (11) , 2026-2032
AI-ASSISTED OCT BIOMARKER QUANTIFICATION REVEALS DISTINCT RETINAL FLUID TRAJECTORIES IN CENTRAL RETINAL VEIN OCCLUSION
Purpose: To characterize longitudinal patterns of intraretinal (IRF) and subretinal fluid (SRF) dynamics using artificial intelligence–assisted optical coherence tomography (OCT) biomarker quantification and to evaluate their association with long-term visual outcomes in eyes with central retinal vein occlusion (CRVO). Methods: Patients with previously treatment-naïve CRVO and a documented 24-month follow-up were retrospectively included. All eyes received intravitreal aflibercept administered according to a treat-and-extend protocol. Spectral-domain OCT scans were analyzed at baseline and after 3 and 24 months. IRF and SRF volumes were quantified using RetinAI Discovery OCT Biomarker Detector (Ikerian AG). Linear regression models were used to assess the association between fluid volumes and 24-month corrected distance visual acuity (CDVA). Patients were clustered according to their IRF trajectories over time to identify distinct fluid-response phenotypes. Results: Out of 173 patients, 64 eyes (64 patients) were included. Baseline IRF and SRF volumes showed no significant association with 24-month CDVA. Cluster analysis of longitudinal IRF trajectories identified four distinct fluid-response patterns. Eyes with low or rapidly resolving IRF achieved the best long-term visual outcomes (median CDVA 73 letters), whereas those with persistent or recurrent IRF showed poorer outcomes (median 53 letters; P = 0.008). Early IRF resolution tended to predict superior visual recovery at 24 months. Conclusion: Artificial intelligence–based volumetric OCT analysis suggests that distinct retinal fluid trajectories in CRVO may have prognostic implications for long-term visual acuity, although these findings are preliminary and require validation. Dynamic IRF resolution patterns may be more informative than static fluid volumes for predicting functional outcomes after anti–vascular endothelial growth factor therapy.
- 1 November 2026
- Published by Wolters Kluwer Health in Retina
- Vol. 46 (11) , 2026-2032
AI-ASSISTED OCT BIOMARKER QUANTIFICATION REVEALS DISTINCT RETINAL FLUID TRAJECTORIES IN CENTRAL RETINAL VEIN OCCLUSION
Purpose: To characterize longitudinal patterns of intraretinal (IRF) and subretinal fluid (SRF) dynamics using artificial intelligence–assisted optical coherence tomography (OCT) biomarker quantification and to evaluate their association with long-term visual outcomes in eyes with central retinal vein occlusion (CRVO). Methods: Patients with previously treatment-naïve CRVO and a documented 24-month follow-up were retrospectively included. All eyes received intravitreal aflibercept administered according to a treat-and-extend protocol. Spectral-domain OCT scans were analyzed at baseline and after 3 and 24 months. IRF and SRF volumes were quantified using RetinAI Discovery OCT Biomarker Detector (Ikerian AG). Linear regression models were used to assess the association between fluid volumes and 24-month corrected distance visual acuity (CDVA). Patients were clustered according to their IRF trajectories over time to identify distinct fluid-response phenotypes. Results: Out of 173 patients, 64 eyes (64 patients) were included. Baseline IRF and SRF volumes showed no significant association with 24-month CDVA. Cluster analysis of longitudinal IRF trajectories identified four distinct fluid-response patterns. Eyes with low or rapidly resolving IRF achieved the best long-term visual outcomes (median CDVA 73 letters), whereas those with persistent or recurrent IRF showed poorer outcomes (median 53 letters; P = 0.008). Early IRF resolution tended to predict superior visual recovery at 24 months. Conclusion: Artificial intelligence–based volumetric OCT analysis suggests that distinct retinal fluid trajectories in CRVO may have prognostic implications for long-term visual acuity, although these findings are preliminary and require validation. Dynamic IRF resolution patterns may be more informative than static fluid volumes for predicting functional outcomes after anti–vascular endothelial growth factor therapy.
- Open Access
- 24 October 2026
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- p. 1-10
Baseline OCT-features predicting retinal atrophy in optic disc swelling
Purpose: To assess optical coherence tomography (OCT) biomarkers at initial presentation of optic disc swelling (ODS) in predicting retinal nerve fibre layer (RNFL) and ganglion cell layer (GCL) atrophy using volumetric macular and optic nerve head (ONH) analysis. Methods: In this retrospective study, patients with first-episode ODS and 6- and 12-month follow-up were included. Spectral-domain OCT (SD-OCT) volumetric scans of the macula and ONH were analysed using an AI-based platform (Discovery). Macular RNFL, ganglion cell-inner plexiform layer (GCL + IPL), and ONH RNFL volumes were quantified across ETDRS grid fields. Longitudinal change was modelled with linear mixed-effects models; predictors of 12-month outcomes were identified by multiple linear regression. Results: Fifty-two eyes from 32 patients (mean age 39 ± 13.8 years) were analysed across papilloedema ( n = 24), uveitic disc oedema ( n = 22), ischaemic ( n = 4), and infiltrative ( n = 2) aetiologies. At baseline, uveitic disc oedema eyes showed significantly higher macular RNFL and GCL + IPL volumes than papilloedema, while ONH RNFL was similarly elevated. All OCT parameters declined significantly over 12months, with greater macular loss in uveitic disc oedema cases ( p < 0.001). GCL + IPL reduction was more pronounced in the uveitic disc oedema group (− 296 ± 241 nL vs. − 110 ± 160 nL) and persisted beyond 6 months only in this group ( p = 0.012). Baseline GCL + IPL volume strongly predicted 12-month GCL + IPL volume loss (β = 0.91, p < 0.001), and worse baseline visual acuity independently predicted more severe GCL + IPL volume loss (β=-317, p = 0.002). ONH RNFL did not predict visual outcomes. Conclusion: ODS is associated with measurable structural change over 12 months. Baseline macular OCT biomarkers, particularly GCL + IPL, predicted 12-month outcomes largely independent of aetiology, and macular OCT may aid risk stratification alongside aetiological diagnosis.
- 24 October 2026
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- p. 1-10
Open AccessBaseline OCT-features predicting retinal atrophy in optic disc swelling
Purpose: To assess optical coherence tomography (OCT) biomarkers at initial presentation of optic disc swelling (ODS) in predicting retinal nerve fibre layer (RNFL) and ganglion cell layer (GCL) atrophy using volumetric macular and optic nerve head (ONH) analysis. Methods: In this retrospective study, patients with first-episode ODS and 6- and 12-month follow-up were included. Spectral-domain OCT (SD-OCT) volumetric scans of the macula and ONH were analysed using an AI-based platform (Discovery). Macular RNFL, ganglion cell-inner plexiform layer (GCL + IPL), and ONH RNFL volumes were quantified across ETDRS grid fields. Longitudinal change was modelled with linear mixed-effects models; predictors of 12-month outcomes were identified by multiple linear regression. Results: Fifty-two eyes from 32 patients (mean age 39 ± 13.8 years) were analysed across papilloedema ( n = 24), uveitic disc oedema ( n = 22), ischaemic ( n = 4), and infiltrative ( n = 2) aetiologies. At baseline, uveitic disc oedema eyes showed significantly higher macular RNFL and GCL + IPL volumes than papilloedema, while ONH RNFL was similarly elevated. All OCT parameters declined significantly over 12months, with greater macular loss in uveitic disc oedema cases ( p < 0.001). GCL + IPL reduction was more pronounced in the uveitic disc oedema group (− 296 ± 241 nL vs. − 110 ± 160 nL) and persisted beyond 6 months only in this group ( p = 0.012). Baseline GCL + IPL volume strongly predicted 12-month GCL + IPL volume loss (β = 0.91, p < 0.001), and worse baseline visual acuity independently predicted more severe GCL + IPL volume loss (β=-317, p = 0.002). ONH RNFL did not predict visual outcomes. Conclusion: ODS is associated with measurable structural change over 12 months. Baseline macular OCT biomarkers, particularly GCL + IPL, predicted 12-month outcomes largely independent of aetiology, and macular OCT may aid risk stratification alongside aetiological diagnosis.
- Open Access
- 17 June 2026
- Published by Elsevier in AJO International
- Vol. 3 (3)
Near real-time monitoring of intravitreal injection outcomes using an epic-integrated ophthalmology data mart
- 17 June 2026
- Published by Elsevier in AJO International
- Vol. 3 (3)
Open AccessNear real-time monitoring of intravitreal injection outcomes using an epic-integrated ophthalmology data mart
- Open Access
- 1 April 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-8
Posterior Capsule Rupture and Vitreous Loss in Cataract Surgery: A Retrospective Analysis from a Swiss Tertiary Center
To determine the incidence of posterior capsule rupture (PCR) and vitreous loss (VL) during cataract surgery in a Swiss tertiary care center. Furthermore, we aimed to evaluate preoperative risk factors associated with PCR/VL, including pseudoexfoliation (PEX), age, type of anesthesia, and the Triemli Cataract Score (TCS), a locally implemented preoperative risk assessment tool for surgical complexity. This retrospective single-center cohort study included all phacoemulsification and refractive lens exchange procedures performed at Stadtspital Zürich between January 2021 and late August 2024. Data were retrieved from the Dendrite clinical database of the TCS and supplemented through manual chart review and surgical reports for identification of intraoperative complications. Univariable and multivariable logistic regression analyses were performed to evaluate associations between preoperative factors and the occurrence of PCR and/or VL. A total of 2’719 eyes were included in the study. PCR and/or VL occurred in 52 eyes (1.9%), including 45 cases of PCR (5 with concomitant VL) and 7 additional cases of isolated VL due to zonulolysis. In univariate analysis, PEX and a TCS ≥3 were significantly associated with an increased risk of PCR and/or VL (OR 2.72; p=0.003 and OR 2.38; p=0.002, respectively), while topical (vs. general) anesthesia was associated with a reduced risk (OR 0.51, p=0.019). In multivariate analysis, only PEX remained an independent risk factor (OR 2.38; p=0.013). The association between TCS ≥3 and PCR/VL just missed statistical significance (OR 1.79; p=0.057). The rate of PCR and/or VL during cataract surgery at a Swiss tertiary care center is comparable to international statistics. PEX is a strong and independent predictor for these complications; although the predictive power of TCS did not reach statistical significance in multivariable analysis, the observed trend suggests that risk-based preoperative scores such as the TCS may support risk-stratification and surgical planning in clinical practice.
- 1 April 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-8
Open AccessPosterior Capsule Rupture and Vitreous Loss in Cataract Surgery: A Retrospective Analysis from a Swiss Tertiary Center
To determine the incidence of posterior capsule rupture (PCR) and vitreous loss (VL) during cataract surgery in a Swiss tertiary care center. Furthermore, we aimed to evaluate preoperative risk factors associated with PCR/VL, including pseudoexfoliation (PEX), age, type of anesthesia, and the Triemli Cataract Score (TCS), a locally implemented preoperative risk assessment tool for surgical complexity. This retrospective single-center cohort study included all phacoemulsification and refractive lens exchange procedures performed at Stadtspital Zürich between January 2021 and late August 2024. Data were retrieved from the Dendrite clinical database of the TCS and supplemented through manual chart review and surgical reports for identification of intraoperative complications. Univariable and multivariable logistic regression analyses were performed to evaluate associations between preoperative factors and the occurrence of PCR and/or VL. A total of 2’719 eyes were included in the study. PCR and/or VL occurred in 52 eyes (1.9%), including 45 cases of PCR (5 with concomitant VL) and 7 additional cases of isolated VL due to zonulolysis. In univariate analysis, PEX and a TCS ≥3 were significantly associated with an increased risk of PCR and/or VL (OR 2.72; p=0.003 and OR 2.38; p=0.002, respectively), while topical (vs. general) anesthesia was associated with a reduced risk (OR 0.51, p=0.019). In multivariate analysis, only PEX remained an independent risk factor (OR 2.38; p=0.013). The association between TCS ≥3 and PCR/VL just missed statistical significance (OR 1.79; p=0.057). The rate of PCR and/or VL during cataract surgery at a Swiss tertiary care center is comparable to international statistics. PEX is a strong and independent predictor for these complications; although the predictive power of TCS did not reach statistical significance in multivariable analysis, the observed trend suggests that risk-based preoperative scores such as the TCS may support risk-stratification and surgical planning in clinical practice.
- Open Access
- 9 October 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (4) , 440-445
Evaluating the risk of recurrence in neovascular age-related macular degeneration using OCT-angiography at the time of treatment exit
Background/aims To find biomarkers on OCT-angiography (OCT-A) that indicate a higher risk of recurrence in neovascular age-related macular degeneration (nAMD) patients before anti-vascular endothelial growth factor (anti-VEGF) therapy termination. Methods Retrospective, observational study. Stable, inactive nAMD patients who had been treated with a treat-and-extend regimen and met the predefined exit criteria were included. The macular neovascularisation (MNV) lesion was imaged on OCT-A. Lesion area, vessel density (VD), fractal dimension and height of feeder vessel were quantified. Patients with disease recurrence after termination were compared with those who stayed inactive. Results Out of 819 eyes diagnosed with nAMD and 281 with a 2-year follow-up, 77 (27.4%) reached the exit criteria. Thirty-four eyes of 33 (15 female) patients with reliable OCT-A were further analysed. Mean age was 80.35 (±9.29) years, the number of injections was 16.68 (±8.22). Treatment duration before exit was 36.15 (±16.63) months. After exit, 23 eyes stayed inactive for a follow-up period of 23.00 (±16.18) months, and 11 experienced recurrence after 13.36 (±9.90) months. VD was significantly higher in the recurrent versus inactive group with 0.60 (±0.15) versus 0.47 (±0.11), p=0.015. There was an insignificant tendency for the protective properties of type 1 MNV and a low feeder vessel. Conclusion OCT-A is useful in the risk calculation for recurrence in patients who are about to discontinue anti-VEGF treatments in nAMD. Patients with a high VD might need closer follow-ups or continued anti-VEGF treatments even if inactive.
- 9 October 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (4) , 440-445
Open AccessEvaluating the risk of recurrence in neovascular age-related macular degeneration using OCT-angiography at the time of treatment exit
Background/aims To find biomarkers on OCT-angiography (OCT-A) that indicate a higher risk of recurrence in neovascular age-related macular degeneration (nAMD) patients before anti-vascular endothelial growth factor (anti-VEGF) therapy termination. Methods Retrospective, observational study. Stable, inactive nAMD patients who had been treated with a treat-and-extend regimen and met the predefined exit criteria were included. The macular neovascularisation (MNV) lesion was imaged on OCT-A. Lesion area, vessel density (VD), fractal dimension and height of feeder vessel were quantified. Patients with disease recurrence after termination were compared with those who stayed inactive. Results Out of 819 eyes diagnosed with nAMD and 281 with a 2-year follow-up, 77 (27.4%) reached the exit criteria. Thirty-four eyes of 33 (15 female) patients with reliable OCT-A were further analysed. Mean age was 80.35 (±9.29) years, the number of injections was 16.68 (±8.22). Treatment duration before exit was 36.15 (±16.63) months. After exit, 23 eyes stayed inactive for a follow-up period of 23.00 (±16.18) months, and 11 experienced recurrence after 13.36 (±9.90) months. VD was significantly higher in the recurrent versus inactive group with 0.60 (±0.15) versus 0.47 (±0.11), p=0.015. There was an insignificant tendency for the protective properties of type 1 MNV and a low feeder vessel. Conclusion OCT-A is useful in the risk calculation for recurrence in patients who are about to discontinue anti-VEGF treatments in nAMD. Patients with a high VD might need closer follow-ups or continued anti-VEGF treatments even if inactive.
- Open Access
- 1 September 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 3307-3316
Implementation of a Modified Risk Stratification Score in Cataract Surgery at a Swiss Public Hospital
Introduction: This study evaluates the impact of a modified risk stratification system on intraoperative complication rates in cataract surgeries conducted at a Swiss Public Hospital. Methods: In this retrospective study cataract surgeries were analyzed before and after implementation of the Triemli Cataract Score (TCS) at a public referral hospital. The TCS was utilized to classify patients preoperatively based on their risk profile, categorizing cases into three levels of complexity: “routine”, “complex”, and “highly complex”. The primary endpoint is the frequency of intraoperative complications pre-/post-TCS implementation, as well as alignment with the designated risk groups. Results: A total of 1776 eyes were included in the study, with 704 eyes (39.6%) assessed prior to and 1072 (60.4%) post-TCS implementation. Overall, intraoperative complications were observed in 146 surgeries (8.2%), with a higher incidence observed before (9.5%) compared to post-TCS (7.4%; p=0.054). Post-TCS, 625 (63.2%) were classified as “routine”, 250 eyes (25.3%) as “complex”, and 113 eyes (11.4%) as “highly complex”, based on their risk factors. The intraoperative complication rate varied significantly among these groups (p=0.014): the lowest rate was seen in the routine group (5.6%), followed by the highly complex group (8.8%), and the highest in the complex group (11.2%). Discussion: Implementing a risk stratification system for cataract surgery enables efficient and consistent preoperative categorization of patients into defined risk groups. This approach has the potential to reduce intraoperative complications, improve the comparability of study outcomes, streamline the classification process for surgeons, and establish structured checkpoints for training ophthalmic surgeons.
- 1 September 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 3307-3316
Open AccessImplementation of a Modified Risk Stratification Score in Cataract Surgery at a Swiss Public Hospital
Introduction: This study evaluates the impact of a modified risk stratification system on intraoperative complication rates in cataract surgeries conducted at a Swiss Public Hospital. Methods: In this retrospective study cataract surgeries were analyzed before and after implementation of the Triemli Cataract Score (TCS) at a public referral hospital. The TCS was utilized to classify patients preoperatively based on their risk profile, categorizing cases into three levels of complexity: “routine”, “complex”, and “highly complex”. The primary endpoint is the frequency of intraoperative complications pre-/post-TCS implementation, as well as alignment with the designated risk groups. Results: A total of 1776 eyes were included in the study, with 704 eyes (39.6%) assessed prior to and 1072 (60.4%) post-TCS implementation. Overall, intraoperative complications were observed in 146 surgeries (8.2%), with a higher incidence observed before (9.5%) compared to post-TCS (7.4%; p=0.054). Post-TCS, 625 (63.2%) were classified as “routine”, 250 eyes (25.3%) as “complex”, and 113 eyes (11.4%) as “highly complex”, based on their risk factors. The intraoperative complication rate varied significantly among these groups (p=0.014): the lowest rate was seen in the routine group (5.6%), followed by the highly complex group (8.8%), and the highest in the complex group (11.2%). Discussion: Implementing a risk stratification system for cataract surgery enables efficient and consistent preoperative categorization of patients into defined risk groups. This approach has the potential to reduce intraoperative complications, improve the comparability of study outcomes, streamline the classification process for surgeons, and establish structured checkpoints for training ophthalmic surgeons.
- Open Access
- 27 February 2025
- Published by Springer Nature in International Journal of Retina and Vitreous
- Vol. 11 (1) , 1-8
High-resolution optical coherence tomography in pigmented choroidal lesions
Purpose: Evaluating High-Resolution Optical Coherence Tomography (HR-OCT) versus standard spectral domain OCT in pigmented choroidal lesions. Methods: We screened a total of 40 subjects with pigmented choroidal lesions. Lesions were imaged on HR-OCT and standard OCT devices with and without enhanced depth imaging (EDI) mode. Images were graded for qualitative and quantitative aspects, like choriocapillaris compression and width, choroidal reflectivity and thickness, amongst others. Results: 32 of the 40 subjects could be included in the image analysis, the rest were excluded due to insufficient imaging. HR-OCT EDI mode allowed visualization of the posterior choroidal extent in 11 lesions (11/32 = 34.4%) versus in six (6/32; 18.8%), four (4/30; 13.3%), and five cases (5/30; 16.7%) in normal HR-OCT (n = 32), standard OCT (n = 30) and OCT EDI mode (n = 30), respectively, albeit not significantly different. Choriocapillaris compression was evident in 10 cases on HR-OCT and equally visible in all imaging modes. Mean choriocapillaris thickness ranged from 11.6 to 13.9 microns (SD range 3.84–4.33), and compressed choriocapillaris thickness similarly ranged from a mean of 7.1 to 7.8 microns (SD range 2.20–3.55). Image quality declined significantly towards the periphery in three out of four modes (p = 0.0077 to p = 0.29). Conclusions: HR-OCT may provide better visibility of retinal and choroidal structures in pigmented choroidal lesions, although image quality is reduced in attempting to image peripheral lesions. Translational relevance: The prototype HR-OCT offers insights into clinical features of pigmented choroidal lesions that are not apparent on conventional OCT imaging. This supports the development of HR-OCTolution OCT devices.
- 27 February 2025
- Published by Springer Nature in International Journal of Retina and Vitreous
- Vol. 11 (1) , 1-8
Open AccessHigh-resolution optical coherence tomography in pigmented choroidal lesions
Purpose: Evaluating High-Resolution Optical Coherence Tomography (HR-OCT) versus standard spectral domain OCT in pigmented choroidal lesions. Methods: We screened a total of 40 subjects with pigmented choroidal lesions. Lesions were imaged on HR-OCT and standard OCT devices with and without enhanced depth imaging (EDI) mode. Images were graded for qualitative and quantitative aspects, like choriocapillaris compression and width, choroidal reflectivity and thickness, amongst others. Results: 32 of the 40 subjects could be included in the image analysis, the rest were excluded due to insufficient imaging. HR-OCT EDI mode allowed visualization of the posterior choroidal extent in 11 lesions (11/32 = 34.4%) versus in six (6/32; 18.8%), four (4/30; 13.3%), and five cases (5/30; 16.7%) in normal HR-OCT (n = 32), standard OCT (n = 30) and OCT EDI mode (n = 30), respectively, albeit not significantly different. Choriocapillaris compression was evident in 10 cases on HR-OCT and equally visible in all imaging modes. Mean choriocapillaris thickness ranged from 11.6 to 13.9 microns (SD range 3.84–4.33), and compressed choriocapillaris thickness similarly ranged from a mean of 7.1 to 7.8 microns (SD range 2.20–3.55). Image quality declined significantly towards the periphery in three out of four modes (p = 0.0077 to p = 0.29). Conclusions: HR-OCT may provide better visibility of retinal and choroidal structures in pigmented choroidal lesions, although image quality is reduced in attempting to image peripheral lesions. Translational relevance: The prototype HR-OCT offers insights into clinical features of pigmented choroidal lesions that are not apparent on conventional OCT imaging. This supports the development of HR-OCTolution OCT devices.
- Open Access
- 24 August 2024
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 9 (1) , e001659
Aflibercept for central retinal vein occlusions: long-term outcomes of a ‘Treat-and-Extend’ regimen
Background/aims This study reports on the long-term functional and anatomical outcomes of patients with central retinal vein occlusion (CRVO) treated under the Bern treat-and-extend (T&E) protocol. Methods Observational study. Treatment-naive patients with CRVO and consecutive macular oedema treated with aflibercept were included. The T&E protocol involved 2 monthly injections followed by an extension based on individual assessments. At each visit, best-corrected visual acuity (BCVA), optical coherence tomography imaging and a 2 mg aflibercept injection were administered. Changes in BCVA, proportion of patients gaining ≥15 letters, central subfield thickness (CST) and treatment intervals were analysed. Results Out of 173 patients, 64 had a follow-up of at least 2 years. BCVA improved from 46.7±25.3 at baseline to 78.3±0.5 at year 9. The proportion of patients with ≥15 letters gained was 56%, 53%, 56%, 62%, 52%, 52%, 43%, 50% and 33% at years 1–9, respectively. CST decreased significantly from 660±242 µm at baseline to 359±63 µm at year 9. Treatment intervals extended from 4 weeks initially to an average of 13.0±4.1 weeks by year 8. Conclusions The T&E regimen for CRVO shows sustained visual improvements and reduced CST over time. Patients maintained stable visual gains for many years, demonstrating the effectiveness of this treatment approach. However, no control group was available to compare our T&E regimen with other strategies.
- 24 August 2024
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 9 (1) , e001659
Open AccessAflibercept for central retinal vein occlusions: long-term outcomes of a ‘Treat-and-Extend’ regimen
Background/aims This study reports on the long-term functional and anatomical outcomes of patients with central retinal vein occlusion (CRVO) treated under the Bern treat-and-extend (T&E) protocol. Methods Observational study. Treatment-naive patients with CRVO and consecutive macular oedema treated with aflibercept were included. The T&E protocol involved 2 monthly injections followed by an extension based on individual assessments. At each visit, best-corrected visual acuity (BCVA), optical coherence tomography imaging and a 2 mg aflibercept injection were administered. Changes in BCVA, proportion of patients gaining ≥15 letters, central subfield thickness (CST) and treatment intervals were analysed. Results Out of 173 patients, 64 had a follow-up of at least 2 years. BCVA improved from 46.7±25.3 at baseline to 78.3±0.5 at year 9. The proportion of patients with ≥15 letters gained was 56%, 53%, 56%, 62%, 52%, 52%, 43%, 50% and 33% at years 1–9, respectively. CST decreased significantly from 660±242 µm at baseline to 359±63 µm at year 9. Treatment intervals extended from 4 weeks initially to an average of 13.0±4.1 weeks by year 8. Conclusions The T&E regimen for CRVO shows sustained visual improvements and reduced CST over time. Patients maintained stable visual gains for many years, demonstrating the effectiveness of this treatment approach. However, no control group was available to compare our T&E regimen with other strategies.
- Open Access
- 7 April 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (8) , 2768
Robot-Assisted Epiretinal Membrane Peeling: A Prospective Assessment of Pre- and Intra-Operative Times and of Surgeons’ Subjective Perceptions
Purpose: The Preceyes Surgical System (PSS) is a robotic assistive device that may enhance surgical precision. This study assessed pre- and intra-operative times and surgeons’ perceptions of robot-assisted epiretinal membrane peeling (RA-MP). Methods: We analyzed the time requirement of three main tasks: the preparation of the PSS (I), patient preparation (II), and surgery (III). Following surgery, the surgeons were asked questions about their experience. Results: RA-MP was performed in nine eyes of nine patients. Task I required an average time of 12.3 min, initially taking 15 min but decreasing to 6 min in the last surgery. Task II showed a mean time of 47.2 (range of 36–65) min. Task III had a mean time of 72.4 (range of 57–100) min. A mean time of 27.9 (range of 9–46) min was necessary for RA-MP. The responses to the questionnaire revealed a trend towards increasing ease and reduced stress as familiarity with the PSS increased. Conclusions: A substantial reduction in pre- and intra-operative times, decreasing to a total of 115 min, was demonstrated. RA-MP was positively anticipated by the surgeons and led to no hand or arm strain while being more complex than manual MP.
- 7 April 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (8) , 2768
Open AccessRobot-Assisted Epiretinal Membrane Peeling: A Prospective Assessment of Pre- and Intra-Operative Times and of Surgeons’ Subjective Perceptions
Purpose: The Preceyes Surgical System (PSS) is a robotic assistive device that may enhance surgical precision. This study assessed pre- and intra-operative times and surgeons’ perceptions of robot-assisted epiretinal membrane peeling (RA-MP). Methods: We analyzed the time requirement of three main tasks: the preparation of the PSS (I), patient preparation (II), and surgery (III). Following surgery, the surgeons were asked questions about their experience. Results: RA-MP was performed in nine eyes of nine patients. Task I required an average time of 12.3 min, initially taking 15 min but decreasing to 6 min in the last surgery. Task II showed a mean time of 47.2 (range of 36–65) min. Task III had a mean time of 72.4 (range of 57–100) min. A mean time of 27.9 (range of 9–46) min was necessary for RA-MP. The responses to the questionnaire revealed a trend towards increasing ease and reduced stress as familiarity with the PSS increased. Conclusions: A substantial reduction in pre- and intra-operative times, decreasing to a total of 115 min, was demonstrated. RA-MP was positively anticipated by the surgeons and led to no hand or arm strain while being more complex than manual MP.
- 23 December 2022
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 241 (01) , 88-94
A Modification of the Inverted Internal Limiting Membrane Flap Technique without Heavy Liquids and Prone Posturing
Primary closure of large macular holes remains challenging, and variations of inverted inner limiting membrane (ILM) flap surgery have been described. In the present retrospective, interventional, single-centre case series, we propose a superior flap design with minimal posturing. Eight eyes of eight patients (four women and four men) in the period between July 2020 and March 2022 underwent 23 G three-port vitrectomy with a superior inverted ILM flap and 20% SF6 endotamponade for a full thickness macular hole (MH) by the same experienced surgeon (F. M. H.). Seven MHs were classified as large (> 400 µm) and one as medium (250 – 400 µm). The mean MLD was 638.0 ± 166.4 µm (range: 353 – 851 µm). MH closure was achieved in all (8/8, 100%) patients with a single surgery. The median best-corrected visual acuity (BCVA) improved from 6/120 (Snellen) (range: finger counting [FC] to 6/19) preoperatively to 6/19 (range: FC to 6/9.5) after surgery, without any intra- or postoperative complications. The superior inverted ILM flap technique seems to be a safe and successful approach for the primary closure of large MHs. Further studies should investigate our proposed surgical technique on a larger population, potentially without air or gas endotamponade. Received: 30 June 2022 Accepted: 19 October 2022 Article published online: 23 December 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 23 December 2022
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 241 (01) , 88-94
A Modification of the Inverted Internal Limiting Membrane Flap Technique without Heavy Liquids and Prone Posturing
Primary closure of large macular holes remains challenging, and variations of inverted inner limiting membrane (ILM) flap surgery have been described. In the present retrospective, interventional, single-centre case series, we propose a superior flap design with minimal posturing. Eight eyes of eight patients (four women and four men) in the period between July 2020 and March 2022 underwent 23 G three-port vitrectomy with a superior inverted ILM flap and 20% SF6 endotamponade for a full thickness macular hole (MH) by the same experienced surgeon (F. M. H.). Seven MHs were classified as large (> 400 µm) and one as medium (250 – 400 µm). The mean MLD was 638.0 ± 166.4 µm (range: 353 – 851 µm). MH closure was achieved in all (8/8, 100%) patients with a single surgery. The median best-corrected visual acuity (BCVA) improved from 6/120 (Snellen) (range: finger counting [FC] to 6/19) preoperatively to 6/19 (range: FC to 6/9.5) after surgery, without any intra- or postoperative complications. The superior inverted ILM flap technique seems to be a safe and successful approach for the primary closure of large MHs. Further studies should investigate our proposed surgical technique on a larger population, potentially without air or gas endotamponade. Received: 30 June 2022 Accepted: 19 October 2022 Article published online: 23 December 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany